drugset / Trial / NCT00718328

Simvastatin For Intracerebral Hemorrhage Study

NCT00718328

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).

Timeline

Start
2008-10
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 80 mg